Michaela Sieger-Tonder, M.D.

Neurologist FMH
Certified Reviewer SIM

Migraines and headaches
General Neurology
Peripheral Neurology
Multiple Sclerosis / Neuroimmunology
Spasticity after stroke
Epileptology
Neuro-oncology

Since 01/2021 Neurologist, Headache Centre Hirslanden Ltd., Switzerland
01/20 – 12/20 Senior Physician, Department of Neurology and Neurosurgery/Brain Tumor Centre, Cantonal Hospital Aarau, Switzerland
10/16 – 12/19 Assistant Physician, Department of Neurology, Cantonal Hospital Aarau, Switzerland
08/15 – 07/16 Assistant Physician, Medical Clinic, Cantonal Hospital Zug, Switzerland
07/11 – 06/15 Assistant Physician, Department of Neurology, University Hospital Zurich, Switzerland
2019 Certificate of proficiency in Electroencephalography (SGKN)
2018 Board-certified neurologist
2015 Certificate of Competence Electroneuromyography (SGKN)
2011 Dissertation: „Significance of semaphorin 7A expression for tumorigenicity and immunogenicity of malignant glioma cells“.
2011 State examination, University of Tübingen, Germany
2004 – 2011 Medical studies, University of Tübingen, Germany

Tonder M, Weller M, Eisele G, Roth P. Chemotherapy. 2014;60(5-6): 375-8. Carboplatin and Etoposide in Heavily Pretreated Patients with Progressive High-Grade Glioma.

Tonder M, Eisele G, Weiss T, Hofer S, Seystahl K, Valavanis A, Stupp R, Weller M, Roth P. Acta Oncol. 2014 Oct;53(10): 1436-40. Addition of lomustine for bevacizumab-refractory recurrent glioblastoma.

Tonder M, Rushing EJ, Grotzer M, Sürücü O, Valavanis A, Buck A, Weller M, Roth P. Neurology. 2014 Feb 18;82(7):56-60. Clinical reasoning: a 30-year-old woman with recurrent seizures and a
cerebral lesion progressing over 2 decades.

Hundsberger T, Tonder M, Hottinger A, Brügge D, Roelcke U, Putora PM, Stupp R, Weller M. J Neurooncol. 2014 Jun;118(2):321-8. Clinical management and outcome of histologically verified adult
brainstem gliomas in Switzerland: a retrospective analysis of 21 patients.

Roth P, Regli L, Tonder M, Weller M. Expert Rev Anticancer Ther. 2013 Nov;13(11):1319-25. Tumor-associated edema in brain cancer patients: pathogenesis and management.

Swiss Society of Clinical Neurophysiology (SGKN)

German
English